Author:
Schultz André,Barrett Andrea,Balding Elizabeth,Billingham Wesley,Branch-Smith Cindy,Grover Zubin,Yikilmaz Gisele,Bourke Crystal,Depiazzi Julie,Sander Nicole,Foster Juliet,Cooper Matthew,Zepf Florian
Abstract
AbstractDiagnosis of chronic disease in a child can result in unresolved grief (UG) in parents. This study aimed to evaluate the efficacy of psychological insight-oriented therapy (IOT) as a treatment for UG compared to disease related education in parents of children with cystic fibrosis (CF). Sequence of delivery, first IOT then disease related education (or vice versa) was also examined, to let all participants experience both interventions. Parents were screened for UG. Parents with UG were randomised to either five 1-h sessions of IOT or five 1-h sessions of education. Measures were assessed pre-intervention, after the first intervention period (primary efficacy assessment), and after the second intervention period (swapping intervention). Forty-seven parents were screened of which 46.8% (22/47) had UG. Median duration of UG was 5 years (range: 6 months–14 years). Anxiety (50% vs. 20%, p = 0.03) and stress (59% vs. 28%, p = 0.03) were significantly more prevalent in parents with UG. There was no difference between arms in the odds of UG resolving either following the first intervention period (OR 0.88; 95% CI 0.5, 1.5) or the second intervention period (OR 0.91; 95% CI 0.5, 1.6). While not statistically significant, adjusted mean values for seven of the eight mental health measures were lower in the IOT (first) arm compared to the ED (first) arm, following the first intervention period. UG is a significant burden for families affected by CF. Provision of disease related education and psychological support, regardless of sequence, can result in resolution of grief.Trial registration number: ACTRN12621000796886, date of registration 24/06/2021, retrospectively registered.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. 12018. Cystic Fibrosis Foundation [U.S.] Patient registry. https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2018-Patient-Registry-Annual-Data-Report.pdf. (Accessed 1 April 2020).
2. Farrell, P. M. The prevalence of cystic fibrosis in the European Union. J. Cyst. Fibros. 7, 450–453 (2008).
3. Breuer, O. et al. Changing prevalence of lower airway infections in young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 200, 590–599 (2019).
4. Ernst, M. M., Johnson, M. C. & Stark, L. J. Developmental and psychosocial issues in cystic fibrosis. Pediatr. Clin. N. Am. 58(865–85), x (2011).
5. Jedlicka-Kohler, I., Gotz, M. & Eichler, I. Parents’ recollection of the initial communication of the diagnosis of cystic fibrosis. Pediatrics 97, 204–209 (1996).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献